Patents Assigned to EOS Biotechnology, Inc.
  • Chemokine receptors and disease
    Publication number: 20020182624
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer and other diseases. Also described herein are methods that can be used to identify modulators of chemokine receptors.
    Type: Application
    Filed: February 28, 2002
    Publication date: December 5, 2002
    Applicant: Eos Biotechnology, Inc.
    Inventor: Albert Zlotnik
  • Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Patent number: 6455668
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal cancer are described.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: September 24, 2002
    Assignee: Eos Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosis of prostate cancer and/or breast cancer, compositions, and methods of screening for prostate cancer and /or breast cancer modulators
    Publication number: 20020068036
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of prostate cancer and/or breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate prostate cancer and/or breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in prostate cancer, breast cancer and other cancers are described.
    Type: Application
    Filed: April 30, 2001
    Publication date: June 6, 2002
    Applicant: EOS BIOTECHNOLOGY, INC.
    Inventors: Peter Hevezi, David Mack, Kurt C. Gish, Keith E. Wilson
  • Methods of diagnosis of colorectal cancer and methods of screening for colorectal cancer modulators
    Patent number: 6316272
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: November 13, 2001
    Assignee: EOS Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Patent number: 6294343
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: September 25, 2001
    Assignee: EOS Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Apparatus and method for concurrent chemical synthesis
    Patent number: 6264891
    Abstract: This invention provides an apparatus for preparing chemical libraries. The apparatus includes (1) a carousel comprising a plurality of reaction mounts having at least one reaction well; (2) a rotator that rotates the carousel step-wise; (3) a fluid delivery system; (4) a drain system; and (5) a programmable computer that controls the operation of the apparatus, including the rotator, the fluid delivery system, the drain system and other systems in the apparatus. The preparation of chemical libraries involves rotating the carousel through a plurality of stations. At each station, a physical step in a reaction protocol is carried out on the reaction wells of the mount docked at the station.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: July 24, 2001
    Assignee: EOS Biotechnology, Inc.
    Inventors: Herbert L. Heyneker, Kim D. Ha, David K. Steinmiller, Victor Simonyi
  • Oligonucleotide arrays
    Patent number: 6057100
    Abstract: The invention relates to novel oligonucleotide arrays.
    Type: Grant
    Filed: June 6, 1997
    Date of Patent: May 2, 2000
    Assignee: EOS Biotechnology, Inc.
    Inventor: Herbert L. Heyneker